Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HP Inc (HPQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

HP Inc vs Regeneron Pharmaceuticals Inc — how do they compare? HP Inc trades at $29.12 (market cap $27.25B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $83.19B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.1× HP Inc's market cap, and HP Inc pays the higher dividend (4.03%). Which is the better fit depends on your goals.

HPQREGN
Market Cap
$27.25B$83.19B
Sector
TechnologyHealth
52-Week High
$30.05$812.27
52-Week Low
$18.20$555.51
Enterprise Value
$34.41B$77.90B
Dividend Yield
4.03%0.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HP Inc

No Aura AI signal available yet.

Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals (REGN) trades at $784.36, up 1.59% today, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong profitability with a net income margin of 27.86% and has beaten EPS estimates in recent quarters. However, multiple class-action lawsuits filed in August 2026 allege inadequate clinical-trial risk disclosures, creating investor uncertainty amid solid financial performance.

Outlook remains supported by earnings momentum and analyst buy ratings, but legal risks and high valuation multiples pose near-term headwinds. Investment opportunity hinges on legal resolution and sustained drug pipeline success, while risks include trial setbacks and regulatory scrutiny.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About HP Inc

HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.

Read more on HPQ

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN